CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
ItalianoFOLLO, MATILDE YUNG
Dettaglio
FOLLO, MATILDE YUNG
DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Docenti di ruolo di IIa fascia
M. Follo; Matilde Y. Follo; F. Matilde; MY Follo; FOLLO MY
Pubblicazioni
Risultati 1 - 20 di 115 (tempo di esecuzione: 0.001 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
|---|---|---|---|---|---|---|---|
| 1 | Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. | Abrams SL, Follo MY, Steelman LS, Lertpiriyapong K, Cocco L, Ratti S, Martelli AM, Candido S, Lib...ra M, Murata RM, Rosalen PL, Montalto G, Cervello M, Gizak A, Rakus D, Mao W, Lombardi P, McCubrey JA. | 2019 | ADVANCES IN BIOLOGICAL REGULATION | 1.01 Articolo in rivista | - | |
| 2 | Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. | S.M. Akula, S. Candido, M. Libra, S.L. Abrams, L.S. Steelman, K. Lertpiriyapong, G. Ramazzotti, S.... Ratti, M.Y. Follo, A.M. Martelli, R.M. Murata, P.L. Rosalen, B. Bueno-Silva, S. Matias de Alencar, G. Montalto, M. Cervello, A. Gizak, D. Rakus, W. Mao, H.-L. Lin, P. Lombardi, J.A. McCubrey. | 2019 | ADVANCES IN BIOLOGICAL REGULATION | 1.01 Articolo in rivista | - | |
| 3 | Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells | Akula S.M.; Candido S.; Abrams S.L.; Steelman L.S.; Lertpiriyapong K.; Cocco L.; Ramazzotti G.; R...atti S.; Follo M.Y.; Martelli A.M.; Murata R.M.; Rosalen P.L.; Bueno-Silva B.; Matias de Alencar S.; Falasca M.; Montalto G.; Cervello M.; Notarbartolo M.; Gizak A.; Rakus D.; Libra M.; McCubrey J.A. | 2020 | ADVANCES IN BIOLOGICAL REGULATION | 1.01 Articolo in rivista | - | |
| 4 | Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients | Follo M.Y.; Mongiorgi S.; Clissa C.; Paolini S.; Martinelli G.; Martelli A.M.; Fioravanti G.; Man...zoli L.; Finelli C.; Cocco L. | 2012 | LEUKEMIA | 1.01 Articolo in rivista | - | |
| 5 | AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES | Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Bosi C; ...Manzoli L; Martinelli G; Cocco L; Baccarani M | 2011 | HAEMATOLOGICA | 4.01 Contributo in Atti di convegno | - | |
| 6 | AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS | Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi ...S; Abbenante MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Cavo M | 2013 | HAEMATOLOGICA | 4.01 Contributo in Atti di convegno | - | |
| 7 | Azacitidine in Myelodysplastic Syndromes: Multicenter Retrospective Study of 34 Long-Responder Patients | Carlo Finelli; Cristina Clissa; Maria Teresa Voso; Maria Antonietta Aloe Spiriti; Massimo Breccia...; Gianluca Gaidano; Monica Crugnola; Maria Benedetta Giannini; Costanza Bosi; Virginia Naso; Matilde Y Follo; Sara Mongiorgi; Giovanni Martinelli; Lucio Cocco; Michele Baccarani | 2012 | BLOOD | 4.02 Riassunto (Abstract) | - | |
| 8 | AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS | Clissa C; Finelli C; Follo MY; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Abbenan...te MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Baccarani M | 2012 | HAEMATOLOGICA | 4.01 Contributo in Atti di convegno | - | |
| 9 | Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study | C. Fill; C. Finelli; M. Gobbi; G. Martinelli; I. Iacobucci; E. Ottaviani; L. Cocco; F. Matilde; A.... Candoni; E. Simeone; M. Miglino; F. Lauria; M. Bocchia; M. Defina; C. Clissa; F. Lanza; P. Spedini; C. Skert; C. Bergonzi; M. Malagola; A. Peli; A. Turra; F. Cattina; C. Colombi; D. Russo | 2011 | LEUKEMIA RESEARCH | 4.02 Riassunto (Abstract) | - | |
| 10 | Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study | Carla Filì; Carlo Finelli; Marco Gobbi; Giovanni Martinelli; Ilaria Iacobucci; Emanuela Ottaviani...; Lucio Cocco; Matilde Y. Follo; Anna Candoni; Erika Simeone; Maurizio Miglino; Francesco Lauria; Monica Bocchia; Marzia Defina; Cristina Clissa; Francesco Lanza; Antonio Curti; Stefania Paolini; Pier Angelo Spedini; Cristina Skert; Cesare Bergonzi; Michele Malagola; Annalisa Peli; Alessandro Turra; Federica Cattina; Chiara Colombi; Domenico Russo | 2010 | BLOOD | 4.01 Contributo in Atti di convegno | - | |
| 11 | B-all complexity: Is targeted therapy still a valuable approach for pediatric patients? | Ratti S.; Lonetti A.; Follo M.Y.; Paganelli F.; Martelli A.M.; Chiarini F.; Evangelisti C. | 2020 | CANCERS | 1.01 Articolo in rivista | ||
| 12 | Cancer therapy and treatments during COVID-19 era | Akula S.M.; Abrams S.L.; Steelman L.S.; Candido S.; Libra M.; Lerpiriyapong K.; Cocco L.; Ramazzo...tti G.; Ratti S.; Follo M.Y.; Martelli A.M.; Blalock W.L.; Piazzi M.; Montalto G.; Cervello M.; Notarbartolo M.; Basecke J.; McCubrey J.A. | 2020 | ADVANCES IN BIOLOGICAL REGULATION | 1.01 Articolo in rivista | - | |
| 13 | Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia | Parisi S.; Finelli C.; Fazio A.; De Stefano A.; Mongiorgi S.; Ratti S.; Cappellini A.; Billi A.M....; Cocco L.; Follo M.Y.; Manzoli L. | 2021 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 1.01 Articolo in rivista | - | |
| 14 | Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes | Finelli, Carlo; Follo, Matilde Y; Stanzani, Marta; Parisi, Sarah; Clissa, Cristina; Mongiorgi, Sa...ra; Barraco, Marilena; Cocco, Lucio | 2016 | CURRENT PHARMACEUTICAL DESIGN | 1.01 Articolo in rivista | - | |
| 15 | Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide | M.Y. Follo; S. Mongiorgi; C. Clissa; M. Stoyanova; S. Paolini; M. Quaranta; G. Martinelli; L. Man...zoli; C. Cocco; C. Finelli | 2013 | LEUKEMIA RESEARCH | 4.01 Contributo in Atti di convegno | - | |
| 16 | CLONAL ACTIVATION OF AKT IN LOW-RISK MDS PATIENTS WITH DEL(5Q) TREATED WITH LENALIDOMIDE | Follo MY; Clissa C; Mongiorgi S; Stoyanova M; Paolini S; Quaranta M; Stanzani M; Martinelli G; Ma...nzoli L; Cocco L; Finelli C | 2013 | HAEMATOLOGICA | 4.01 Contributo in Atti di convegno | - | |
| 17 | Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q) | Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carmen Baldazzi; Marta Stanzani;... Michele Baccarani; Lucio Cocco | 2013 | BLOOD | 4.01 Contributo in Atti di convegno | - | |
| 18 | Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy. | Steelman, Ls; Fitzgerald, T; Lertpiriyapong, K; Cocco, L; Follo, My; Martelli, Am; Neri, Lm; Marm...iroli, S; Libra, M; Candido, S; Nicoletti, F; Scalisi, A; Fenga, C; Drobot, L; Rakus, D; Gizak, A; Laidler, P; Dulinska-Litewka, J; Basecke, J; Mijatovic, S; Maksimovic-Ivanic, D; Montalto, G; Cervello, M; Milella, M; Tafuri, A; Demidenko, Z; Abrams, Sl; Mccubrey, Ja. | 2016 | CURRENT PHARMACEUTICAL DESIGN | 1.01 Articolo in rivista | - | |
| 19 | DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES | Follo, My; Mongiorgi, S; Clissa, C; Stanzani, M; Poli, A; Lonetti, A; Cappellini, A; Manzoli, L; ...Cocco L, 1; Finelli, C | 2014 | HAEMATOLOGICA | 4.02 Riassunto (Abstract) | - | |
| 20 | Early Increase of Phospholipase Cbeta1 (PI-PLCbeta1) Gene Expression Predicts Azacitidine Responsiveness in MDS Patients | Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carla Filì; Costanza Bosi; Maril...isa Quaranta; Stefania Paolini; Anna Maria Billi; Marco Gobbi; Michele Baccarani; Domenico Russo; Giovanni Martinelli; Lucia Manzoli; Lucio Cocco | 2012 | BLOOD | 4.02 Riassunto (Abstract) | - |
Copyright © 2021